Detalles de la búsqueda
1.
Prediction of BRCA1 germ-line mutation status in patients with breast cancer using histoprognosis grade, MS110, Lys27H3, vimentin, and KI67.
Pathobiology
; 80(5): 219-27, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23614934
2.
Long Terms Follow-Up of the Randomized MetaspHER Study Comparing Intravenous Versus Subcutaneous Trastuzumab in Patients' With HER2-Positive Metastatic Breast Cancer.
Clin Breast Cancer
; 23(7): e412-e419, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37423801
3.
[Targeted chemotherapy for breast cancer: patients perception of the use of tumor gene profiling approaches to better adapt treatments]. / Chimiothérapie ciblée du cancer du sein basée sur une analyse génomique de la tumeur - Adhésion des patientes, craintes et malentendus.
Med Sci (Paris)
; 28 Spec No 1: 24-7, 2012 Mar.
Artículo
en Francés
| MEDLINE | ID: mdl-22494653
4.
A gene expression signature identifies two prognostic subgroups of basal breast cancer.
Breast Cancer Res Treat
; 126(2): 407-20, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-20490655
5.
Gene expression profile predicts outcome after anthracycline-based adjuvant chemotherapy in early breast cancer.
Breast Cancer Res Treat
; 127(2): 363-73, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20585850
6.
Circulating Tumor Cells and Bevacizumab Pharmacokinetics during Neoadjuvant Treatment Combining Chemotherapy and Bevacizumab for Early Breast Cancer: Ancillary Analysis of the AVASTEM Trial.
Cancers (Basel)
; 13(1)2021 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33466225
7.
Eribulin Efficacy on Brain Metastases in Heavily Pretreated Patients with Metastatic Breast Cancer.
J Clin Med
; 10(6)2021 Mar 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-33803894
8.
Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trial.
Genome Med
; 13(1): 87, 2021 05 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-34006291
9.
Efficacy of trastuzumab in routine clinical practice and after progression for metastatic breast cancer patients: the observational Hermine study.
Oncologist
; 15(8): 799-809, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20671105
10.
Protein profiling of human breast tumor cells identifies novel biomarkers associated with molecular subtypes.
Mol Cell Proteomics
; 7(8): 1420-33, 2008 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-18426791
11.
Association of GATA3, P53, Ki67 status and vascular peritumoral invasion are strongly prognostic in luminal breast cancer.
Breast Cancer Res
; 11(2): R23, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19405945
12.
Docetaxel first-line therapy in HER2-negative advanced breast cancer: a cohort study in patients with prospectively determined HER2 status.
Anticancer Drugs
; 20(10): 946-52, 2009 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-19741502
13.
Stem Cells Inhibition by Bevacizumab in Combination with Neoadjuvant Chemotherapy for Breast Cancer.
J Clin Med
; 8(5)2019 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31064127
14.
Safety Results and Analysis of Eribulin Efficacy according to Previous Microtubules-Inhibitors Sensitivity in the French Prospective Expanded Access Program for Heavily Pre-treated Metastatic Breast Cancer.
Cancer Res Treat
; 50(4): 1226-1237, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-29281873
15.
PIKHER2: A phase IB study evaluating buparlisib in combination with lapatinib in trastuzumab-resistant HER2-positive advanced breast cancer.
Eur J Cancer
; 86: 28-36, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28950146
16.
Similar response profile to neoadjuvant chemotherapy, but different survival, in inflammatory versus locally advanced breast cancers.
Oncotarget
; 8(39): 66019-66032, 2017 Sep 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29029489
17.
[Impact of Her2 and BRCA1/2 status in high-dose chemotherapy and autologous stem cells transplantation in the treatment of breast cancer: The Institut Paoli Calmettes' experience]. / Expérience de l'institut Paoli-Calmettes concernant la chimiothérapie à haute dose et autogreffe de cellules souches hématopoïétiques pour la prise en charge des cancers mammaires : impact du statut Her2 et BRCA1/2.
Bull Cancer
; 104(4): 332-343, 2017 Apr.
Artículo
en Francés
| MEDLINE | ID: mdl-28214007
18.
Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group.
J Clin Oncol
; 23(19): 4265-74, 2005 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15911866
19.
Pathological response to preoperative concurrent chemo-radiotherapy for breast cancer: results of a phase II study.
Eur J Cancer
; 42(14): 2286-95, 2006 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-16893641
20.
Invasive ductal breast carcinoma with predominant intraductal component: Clinicopathological features and prognosis.
Breast
; 27: 8-14, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-27212694